Status:

RECRUITING

RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE)

Lead Sponsor:

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Collaborating Sponsors:

European Renal Association - European Dialysis and Transplant Association

Conditions:

End Stage Renal Disease on Dialysis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Background: The thrice-weekly hemodialysis (HD) regimen is widely accepted as a standard prescription. The concept of incremental dialysis has been established as a possible alternative for patients w...

Detailed Description

The majority of dialysis patients starting hemodialysis (HD) are currently treated with a fixed dose thrice-weekly HD (3HD/wk). The 3HD/wk regimen has been assumed, until recently, almost as a dogma i...

Eligibility Criteria

Inclusion

  • Adults aged \> 18 years
  • Start of maintenance hemodialysis treatment due to advanced CKD stage 5D
  • Patients who are about to start HD or have already started HD within a period of ≤ 2 weeks
  • Glomerular filtration rate \<= 10 mL/min/1.73 m2, as estimated by means of CKD-EPI formula.

Exclusion

  • Age \< 18 years
  • Acute kidney injury or acute on chronic kidney injury
  • eGFR higher than 10 mL/min/1.73 m2
  • UO \< 600 mL/day
  • Already treated with other replacement therapies (peritoneal dialysis or kidney transplant)
  • Unable or unwilling to give informed consent.
  • Unable to comply with trial procedures, e.g., collection of UO.
  • Likely survival prognosis or planned modality or centre transfer \< 6 months.
  • Patients who are in the waiting list for a living kidney transplant
  • Associated diseases: active neoplastic disease; refractory congestive heart failure (type IV NYHA, ejection fraction ≤ 30%) requiring high ultrafiltration volumes per session.

Key Trial Info

Start Date :

May 10 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

190 Patients enrolled

Trial Details

Trial ID

NCT04360694

Start Date

May 10 2021

End Date

December 31 2026

Last Update

June 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Azienda Ospedaliero Universitaria Consorziale Policlinico

Bari, Italy, 70124